Using Metabolomics in Diabetes Management with Traditional Chinese Medicine: A Review
Authors:
- 1 January 2021
- journal article
- review article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 49 (08) , 1813-1837
Abstract
The incidence of diabetes worldwide continues to rise, placing a huge economic and medical burden on human society. More than 90% of diabetic cases are type 2 diabetes (T2D). At present, the pathogenesis of T2D is not yet fully understood. Metabolomics uses high-resolution analytical techniques (typically NMR and MS) to help identify biomarkers associated with the risk of T2D and reveal potential pathogenesis. Many metabolites such as branched-chain amino acids (BCAAs), aromatic amino acids, glycine, 2-hydroxybutyric acid (2-HB), lysophosphatidylcholine (LPC) (18:2), and trehalose have proven to be biomarkers of T2D. Insulin resistance (IR) induced by BCAA in T2D mice is related to the activation of mammalian target of rapamycin (mTOR) and phosphorylation of insulin receptor substrate-1 (IRS1). Incomplete LCFA -oxidation promote acylcarnitine byproduct accumulation and stimulates proinflammatory NF B-related pathways to inhibit insulin action. Traditional Chinese Medicine (TCM) presents unique advantages in the treatment of T2D. Multiple metabolites and metabolic pathways have been identified in the treatment of TCM, providing valuable biomarkers and novel targets for drug therapy and pharmacological mechanism. Therefore, this paper reviews the modern achievements of metabolomics in T2D research and the progress of TCM management in recent years, in order to provide valuable information for related research.
Keywords
Funding Information
- Hebei Administration of Traditional Chinese Medicine (2020055)
This publication has 90 references indexed in Scilit:
- 2-Aminoadipic acid is a biomarker for diabetes riskJournal of Clinical Investigation, 2013
- Novel biomarkers for pre‐diabetes identified by metabolomicsMolecular Systems Biology, 2012
- Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in HumansCirculation, 2012
- Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humansJournal of Clinical Investigation, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American WomenPLOS ONE, 2010
- Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological SettingPLOS ONE, 2010
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic PopulationPLOS ONE, 2010
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyThe Lancet, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009